Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Bürger, C; Shirsath, N; Lang, V; Diehl, S; Kaufmann, R; Weigert, A; Han, YY; Ringel, C; Wolf, P.
Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice.
Acta Derm Venereol. 2017; 97(9):1087-1094
Doi: 10.2340/00015555-2724
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Shirsath Nitesh Pralhad
- Wolf Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The mTOR (mechanistic target of rapamycin) inhibitor rapamycin has long been known for its immune suppressive properties, but it has shown limited therapeutic success when given systemically to patients with psoriasis. Recent data have shown that the mTOR pathway is hyperactivated in lesional psoriatic skin, which probably contributes to the disease by interfering with maturation of keratinocytes. This study investigated the effect of topical rapamycin treatment in an imiquimod-induced psoriatic mouse model. The disease was less severe if the mice had received rapamycin treatment. Immunohistological analysis revealed that rapamycin not only prevented the activation of mTOR signalling (P-mTOR and P-S6 levels), but almost normalized the expression of epidermal differentiation markers. In addition, the influx of innate immune cells into the draining lymph nodes was partially reduced by rapamycin treatment. These data emphasize the role of mTOR signalling in the pathogenesis of psoriasis, and support the investigation of topical mTOR inhibition as a novel anti-psoriatic strategy.
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Topical -
- Aminoquinolines - adverse effects
- Animals -
- Caspase 14 - metabolism
- Dendritic Cells - metabolism
- Disease Models, Animal -
- Imiquimod -
- Immunosuppressive Agents - pharmacology
- Keratin-10 - metabolism
- Keratin-14 - metabolism
- Ki-67 Antigen - metabolism
- Langerhans Cells - metabolism
- Lymph Nodes - metabolism
- Macrophages - metabolism
- Membrane Proteins - metabolism
- Mice, Inbred BALB C -
- Neovascularization, Physiologic - drug effects
- Protein Precursors - metabolism
- Psoriasis - chemically induced
- Psoriasis - drug therapy
- Sirolimus - pharmacology
- Skin - metabolism
- TOR Serine-Threonine Kinases - antagonists & inhibitors
- Find related publications in this database (Keywords)
- psoriasis
- imiquimod
- rapamycin
- mTORC